Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification

SIMPLE SUMMARY: Acute myeloid leukemia (AML) is a devastating but potentially curable disease. The updated version of the European Leukemia Net (ELN) 2017 genetic risk stratification is used as the standard for the prognosis and classification of AML. In the present study, we evaluated the prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tong-Yoon, Park, Silvia, Kwag, Daehun, Lee, Jong-Hyuk, Lee, Joonyeop, Min, Gi-June, Park, Sung-Soo, Jeon, Young-Woo, Shin, Seung-Hawn, Yahng, Seung-Ah, Yoon, Jae-Ho, Lee, Sung-Eun, Cho, Byung-Sik, Eom, Ki-Seong, Kim, Yoo-Jin, Lee, Seok, Min, Chang-Ki, Cho, Seok-Goo, Lee, Jong-Wook, Kim, Hee-Je
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265052/
https://www.ncbi.nlm.nih.gov/pubmed/35804971
http://dx.doi.org/10.3390/cancers14133199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265052/
https://www.ncbi.nlm.nih.gov/pubmed/35804971
http://dx.doi.org/10.3390/cancers14133199

Ejemplares similares